Article

LCP-FRAP Assay for Pre-Screening Membrane Proteins for in Meso Crystallization.

Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037 USA.
Crystal Growth & Design (Impact Factor: 4.56). 02/2008; 8(12):4307-4315. DOI: 10.1021/cg800778j
Source: PubMed

ABSTRACT Fluorescence recovery after photobleaching was used to study the diffusion of two integral membrane proteins, bacteriorhodopsin and beta2-adrenergic receptor, in lipidic cubic phase (LCP). We found that the diffusion properties within the LCP matrix strongly depend on the protein construct and applied screening conditions. Common precipitants often induce restriction on diffusion of proteins in LCP and thereby impede their chances for crystallization. A high protein mobile fraction and a fast diffusion rate correlate very well with known crystallization conditions. Using this knowledge, one can now pre-screen precipitant conditions with microgram quantities of material to rule out conditions that are not conducive to diffusion, nucleation, and crystal growth. The results of this assay will narrow membrane protein crystallization space by identifying suitable protein constructs, stabilizing compounds and precipitant conditions amenable to in meso crystallization. Crystallization pre-screening will significantly increase the chances of obtaining initial crystal hits, expediting efforts in generating high-resolution structures of challenging membrane protein targets.

Download full-text

Full-text

Available from: Jeffrey Liu, Apr 30, 2014
0 Followers
 · 
192 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Crucial as molecular sensors for many vital physiological processes, seven-transmembrane domain G protein-coupled receptors (GPCRs) comprise the largest family of proteins targeted by drug discovery. Together with structures of the prototypical GPCR rhodopsin, solved structures of other liganded GPCRs promise to provide insights into the structural basis of the superfamily's biochemical functions and assist in the development of new therapeutic modalities and drugs. One of the greatest technical and theoretical challenges to elucidating and exploiting structure-function relationships in these systems is the emerging concept of GPCR conformational flexibility and its cause-effect relationship for receptor-receptor and receptor-effector interactions. Such conformational changes can be subtle and triggered by relatively small binding energy effects, leading to full or partial efficacy in the activation or inactivation of the receptor system at large. Pharmacological dogma generally dictates that these changes manifest themselves through kinetic modulation of the receptor's G protein partners. Atomic resolution information derived from increasingly available receptor structures provides an entrée to the understanding of these events and practically applying it to drug design. Supported by structure-activity relationship information arising from empirical screening, a unified structural model of GPCR activation/inactivation promises to both accelerate drug discovery in this field and improve our fundamental understanding of structure-based drug design in general. This review discusses fundamental problems that persist in drug design and GPCR structural determination.
    Pharmacological reviews 12/2011; 63(4):901-37. DOI:10.1124/pr.110.003350 · 18.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Over the past three decades, the Torpedo californica nicotinic acetylcholine receptor (nAChR) has been one of the most extensively studied membrane protein systems. However, the effects of detergent solubilization on nAChR stability and function are poorly understood. The use of lipid-analog detergents for nAChR solubilization has been shown to preserve receptor stability and functionality. The present study used lipid-analog detergents from phospholipid-analog and cholesterol-analog detergent families for solubilization and affinity purification of the receptor and probed nAChR ion channel function using planar lipid bilayers (PLBs) and stability using analytical size exclusion chromatography (A-SEC) in the detergent-solubilized state. We also examined receptor mobility on the lipidic cubic phase (LCP) by measuring the nAChR mobile fraction and diffusion coefficient through fluorescence recovery after photobleaching (FRAP) experiments using lipid-analog and non-lipid-analog detergents. Our results show that it is possible to isolate stable and functional nAChRs using lipid-analog detergents, with characteristic ion channel currents in PLBs and minimal aggregation as observed in A-SEC. Furthermore, fractional mobility and diffusion coefficient values observed in FRAP experiments were similar to the values observed for these parameters in the recently LCP-crystallized β(2)-adrenergic receptor. The overall results show that phospholipid-analog detergents with 16 carbon acyl-chains support nAChR stability, functionality and LCP mobility.
    Journal of Membrane Biology 09/2011; 243(1-3):47-58. DOI:10.1007/s00232-011-9392-4 · 2.17 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Opioids have been the mainstays to alleviate pain for millennia. The opioid receptors responsible for analgesia are G protein-coupled receptors (GPCRs) which bind several endogenous ligands and couple to multiple isoforms of the Gi/o family of G proteins. Numerous studies have promoted a theory of requisite opioid receptor oligomerization. However, recent reports have illustrated that prototypical GPCRs are fully capable of activating their cognate G proteins as monomers. We therefore set out to determine if the monomeric form of the mu-opioid receptor (MOR) is the minimal functional unit for effecient G protein coupling and signaling. To investigate this question a yellow fluorescent protein-MOR fusion protein (YMOR) was constructed and expressed in insect cells to facilitate high expression levels. YMOR displays appropriate function, as it binds ligands with high affinity, induces agonist-stimulated [35S]GTP-gamma-S binding to Galpha-i, and is allosterically regulated by coupled Gi protein heterotrimer in insect cell membranes. A novel purification scheme was developed to purify active YMOR, which was then reconstituted into a phospholipid bilayer in the form of high density lipoprotein (HDL) particles. Single particle imaging of fluorescently-labeled YMOR confirmed the receptor was monomeric in HDL particles. Just as in membrane preparations, monomeric YMOR binds alkaloid and peptide antagonists and agonists with high affinity, activates coupled Gi and Go heterotrimers, and is subject to allosteric regulation by both Gi and Go. Furthermore, experiments measuring Galpha stimulation suggest that monomeric YMOR can support differential activation of Gi protein heterotrimers. These data illustrate that the monomeric form of MOR is indeed the minimal functional unit for G protein coupling. In additional studies, single molecule imaging of a Cy3-labeled MOR agonist, [Lys7, Cys8]dermorphin, illustrate a novel method for investigating GPCR-ligand binding and suggests that one molecule of agonist binds per monomeric YMOR. While the role of oligomerization of opioid receptors continues to be debated, this work has shown that it is not essential for G protein coupling in vivo. It is possible that opioid receptor oligomerization is involved in differential arrestin recruitment and/or desensitization and internalization, where it may play a role in the development of tolerance to opioids in vivo. Ph.D. Pharmacology University of Michigan, Horace H. Rackham School of Graduate Studies http://deepblue.lib.umich.edu/bitstream/2027.42/63783/1/akuszak_1.pdf